MyJournals Home  

RSS FeedsPharmaceuticals, Vol. 12, Pages 92: CDK8-Novel Therapeutic Opportunities (Pharmaceuticals)

 
 

19 june 2019 12:00:50

 
Pharmaceuticals, Vol. 12, Pages 92: CDK8-Novel Therapeutic Opportunities (Pharmaceuticals)
 




Improvements in cancer therapy frequently stem from the development of new small-molecule inhibitors, paralleled by the identification of biomarkers that can predict the treatment response. Recent evidence supports the idea that cyclin-dependent kinase 8 (CDK8) may represent a potential drug target for breast and prostate cancer, although no CDK8 inhibitors have entered the clinics. As the available inhibitors have been recently reviewed, we focus on the biological functions of CDK8 and provide an overview of the complexity of CDK8-dependent signaling throughout evolution and CDK8-dependent effects that may open novel treatment avenues.


Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
76 viewsCategory: Medicine, Pharmacology
 
Pharmaceuticals, Vol. 12, Pages 93: Cellular Senescence and Iron Dyshomeostasis in Alzheimer`s Disease (Pharmaceuticals)
Pharmaceuticals, Vol. 12, Pages 95: Therapeutic Potential of Kappa Opioid Agonists (Pharmaceuticals)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn